Willkommen bei Valicare!
-
Rufen Sie an: +49 69 153 293 701
Mehr erfahren -
ATMP Grundlagen Seminar am 28. und 29.04.2021: jetzt informieren und anmelden!
Mehr erfahren
Events
-
11 Mai 202114 Mai 2021Wien / Österreich PBP World Meeting 12. Welttreffen über Pharmazeutik, Biopharmazie und pharmazeutische Technologie
-
28 Mai 2021Online Anforderungen an die Herstellung und Prüfung von ATMPs Diese virtuelle Block-Vorlesung, durchgeführt von Dr. Hans-Georg Eckert, Senior GMP Consultant der Valicare GmbH, für Studenten der Hochschule Fresenius, ist auch für externe Teilnehmer geöffnet.
-
05 Okt 202106 Okt 2021Online 2nd APV Interactive Workshop on ATMP Am 5. und 6. Oktober 2021 wird der 2. APV-Experten-Workshop diesmal zum Thema „Bridging standard pharma concepts and ATMP” stattfinden.
Nachrichten aus aller Welt
Unser internationaler Pressespiegel zeigt eine Auswahl an Nachrichten und neusten Artikel zu den Themen Arzneimittel neuartiger Therapien (ATMP), Chimäre Antigenrezeptor(CAR)-T-Zell-Therapie, Tumor infiltrierende Lymphozyten (TIL) und biotechnologisch bearbeitete Gewebeprodukte (TEP).
Ein Hoffnungsschimmer: Neue Waffe im Kampf gegen Lebererkrankungen
01.05.2021 | ZephyrnetNiigata, Japan - Forscher der Niigata University, der University of Tokyo, der Osaka University und der Tokyo Medical University, Japan ...
A Look Back at the FDA News from April 2021
30.04.2021 | Targeted OncologyDuring April, the FDA granted approvals to 6 therapies across KRAS wild types, triple-negative breast cancer, gastric cancer, endometrial ...
Legend Biotech Announces Submission of European Marketing Authorisation Application for BCMA CAR-T Therapy Ciltacabtagene Autoleucel (cilta-cel) for the Treatment of Relapsed and/or Refractory Multiple Myeloma
30.04.2021 | Le Lezard (EN)
Natural Killer Cells and Regulatory T Cells Cross Talk in Hepatocellular Carcinoma: Exploring Therapeutic Options for the Next Decade
30.04.2021 | FrontiersDespite major advances in immunotherapy, hepatocellular carcinoma (HCC) remains a challenging target. Natural Killer (NK) cells are crucial ...
How metabolism bridles cytotoxic CD8+ T cells through epigenetic modifications
29.04.2021 | Science DirectHighlights The tumor microenvironment forms a metabolic barrier against cytotoxic CD8+ T cells, thus hampering current immunotherapeutic ...
Pharmastandort Deutschland nach Corona-Pandemie: Mehr Mut, mehr bewegen
29.04.2021 | Pharma Fakten
Smart cell therapies for solid cancers ready to move toward clinical trials
29.04.2021 | Medical XpressImmunotherapies that fight cancer have been a life-saving advancement for many patients, but the approach only works on a few types of ...
Revolutioniert LEOPARD die Diagnostik?
29.04.2021 | Frankfurt-Live
Researchers Present New Insights in the Fight Against COVID-19
28.04.2021 | Laboratory EquipmentScientists from around the world are gathering to share the latest research at the forefront of biology during the Experimental Biology (EB ...
FDA Grants Orphan Drug Designation to Novel TIL Therapy for Advanced-Stage Melanoma
27.04.2021 | Targeted OncologyThe FDA has granted orphan drug designation to ITIL-168 for the treatment of stage IIB to IV melanoma, an investigational, autologous cell ...
EMA PRIME status granted for Vertex, CRISPR Therapeutics’ gene therapy CTX001
27.04.2021 | PharmaTimesVertex Pharmaceuticals and CRISPR Therapeutics’ gene therapy CTX001 has been granted a Priority Medicines (PRIME) designation from the ...
Clinical Catch-Up: April 19-23
26.04.2021 | Bio SpacePublished: Apr 26, 2021 By Mark Terry It was a busy week for non-COVID-19-related clinical trial news, while fairly quiet on the COVID-19 ...
Remote controlling of CAR-T cells and toxicity management: Molecular switches and next generation CARs
24.04.2021 | Science DirectHighlight • The emergence of CAR-T cell therapy with its exciting results attained in patients with relapsed and refractory hematological ...
Macrophage Biology and Mechanisms of Immune Suppression in Breast Cancer
23.04.2021 | FrontiersMacrophages are crucial innate immune cells that maintain tissue homeostasis and defend against pathogens; however, their infiltration into ...
Clinical Relevance of CD4 Cytotoxic T Cells in High-Risk Neuroblastoma
22.04.2021 | FrontiersNeuroblastoma is the most common extracranial childhood solid tumor. The majority of high-risk neuroblastoma is resistant/refractory to the ...
Valicare – kompetent, zuverlässig & effizient
Sie haben wenig Zeit und möchten trotzdem wissen, welche Dienstleistungen die Valicare GmbH anbietet?